Determinants of pulmonary hypertension in left ventricular dysfunction

Area of Science:

• Cardiology
• Cardiovascular Medicine
• Pulmonary Medicine

Background:

• Pulmonary hypertension (PH) in patients with left ventricular dysfunction (LVD) is linked to poor outcomes.
• The precise contribution of cardiac functional abnormalities to PH in LVD remains unclear.

Purpose of the Study:

• To investigate the determinants of pulmonary hypertension in patients diagnosed with left ventricular dysfunction.
• To clarify the relationship between cardiac function parameters and the presence of PH in this patient cohort.

Main Methods:

• Prospective measurement of systolic pulmonary artery pressure (sPAP) using Doppler echocardiography in 102 patients with LVD (ejection fraction < 50%).
• Quantification of left ventricular systolic and diastolic function, functional mitral regurgitation, cardiac output, and left atrial volume.
• Multivariate analysis to identify independent predictors of sPAP.

Main Results:

• Elevated sPAP was observed in patients with LVD (mean 51 ± 14 mm Hg), with wide individual variation.
• Mitral deceleration time (shorter) and mitral effective regurgitant orifice (larger) were the strongest predictors of sPAP.
• Age, mitral deceleration time, and mitral effective regurgitant orifice were independent predictors of sPAP; ejection fraction was not.

Conclusions:

• Pulmonary hypertension is a frequent and highly variable complication in patients with left ventricular dysfunction.
• PH in LVD is primarily associated with diastolic dysfunction and functional mitral regurgitation, rather than the degree of systolic dysfunction.
• Assessment of diastolic function and quantification of mitral regurgitation are crucial in managing patients with LVD and PH.